RWM
ROIV icon

Rialto Wealth Management’s Roivant Sciences ROIV Stock Holding History

Rialto Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Buy
38
+8
+27% +$206 ﹤0.01% 1083
2025
Q4 		$651 Buy
30
+19
+173% +$375 ﹤0.01% 1148
2025
Q3 		$167 Buy
+11
New +$136 ﹤0.01% 1527

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rialto Wealth Management's ROIV Position: Q1 2026 in Review

Rialto Wealth Management increased its Roivant Sciences (ROIV) stake by 27% in Q1 2026, buying an estimated $206 and bringing the position to 38 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Rialto Wealth Management first reported a position in ROIV in Q3 2025 and has held it in 3 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Rialto Wealth Management held 38 shares of Roivant Sciences worth $1.05K as of Q1 2026.
  • Rialto Wealth Management bought 8 Roivant Sciences shares in Q1 2026, an estimated $206.
  • Roivant Sciences made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #1083 holding.
  • Rialto Wealth Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 3 quarters since.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.